BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23404657)

  • 1. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
    Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
    Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer.
    Li J; Chen P; Li XQ; Bao QL; Dai CH; Ge LP
    Int J Cancer; 2013 Mar; 132(5):1098-104. PubMed ID: 22930255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of MAT3 gene expression in NSCLC.
    Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
    Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.
    Monzó M; Rosell R; Felip E; Astudillo J; Sánchez JJ; Maestre J; Martín C; Font A; Barnadas A; Abad A
    J Clin Oncol; 1999 Jul; 17(7):2100-4. PubMed ID: 10561264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
    Liu XY; Chen G; Wang Z; Liu FY
    Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
    Benlloch S; Galbis-Caravajal JM; Alenda C; Peiró FM; Sanchez-Ronco M; Rodríguez-Paniagua JM; Baschwitz B; Rojas E; Massutí B
    Ann Oncol; 2009 Jan; 20(1):91-7. PubMed ID: 18664559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression.
    Nwogu CE; Yendamuri S; Tan W; Kannisto E; Bogner P; Morrison C; Cheney R; Dexter E; Picone A; Hennon M; Hutson A; Reid M; Adjei A; Demmy TL
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):702-7; discussion 707-8. PubMed ID: 23414988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
    Takeuchi H; Morton DL; Elashoff D; Hoon DS
    Int J Cancer; 2005 Dec; 117(6):1032-8. PubMed ID: 15986442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer.
    Hüyük M; Fiocco M; Postmus PE; Cohen D; von der Thüsen JH
    Histopathology; 2023 Apr; 82(5):650-663. PubMed ID: 36282087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node occult micrometastasis in patients with non-small cell lung carcinoma: genetic diagnosis and its impact on prognosis.
    Wang Z; Liu XY; Liu FY; Chen JH
    Ai Zheng; 2003 Nov; 22(11):1204-8. PubMed ID: 14613654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
    Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
    Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
    Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.